Academic Journal
View in EDS

Subcutaneous or Transvenous Defibrillator Therapy

Bibliographic Details
Title: Subcutaneous or Transvenous Defibrillator Therapy
Authors: Knops, RE, Olde Nordkamp, LRA, Delnoy, P-PHM, Boersma, LVA, Kuschyk, J, El-Chami, MF, Bonnemeier, H, Behr, ER, Brouwer, TF, Kääb, S, Mittal, S, Quast, A-FBE, Smeding, L, van der Stuijt, W, de Weger, A, de Wilde, KC, Bijsterveld, NR, Richter, S, Brouwer, MA, de Groot, JR, Kooiman, KM, Lambiase, PD, Neuzil, P, Vernooy, K, Alings, M, Betts, TR, Bracke, FALE, Burke, MC, de Jong, JSSG, Wright, DJ, Tijssen, JGP, Wilde, AAM, PRAETORIAN Investigators
Source: The New England Journal of Medicine , 383 (6) pp. 526-536. (2020)
Publication Year: 2020
Collection: University College London: UCL Discovery
Description: BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies. METHODS: We conducted a noninferiority trial in which patients with an indication for an ICD but no indication for pacing were assigned to receive a subcutaneous ICD or transvenous ICD. The primary end point was the composite of device-related complications and inappropriate shocks; the noninferiority margin for the upper boundary of the 95% confidence interval for the hazard ratio (subcutaneous ICD vs. transvenous ICD) was 1.45. A superiority analysis was prespecified if noninferiority was established. Secondary end points included death and appropriate shocks. RESULTS: A total of 849 patients (426 in the subcutaneous ICD group and 423 in the transvenous ICD group) were included in the analyses. At a median follow-up of 49.1 months, a primary end-point event occurred in 68 patients in the subcutaneous ICD group and in 68 patients in the transvenous ICD group (48-month Kaplan-Meier estimated cumulative incidence, 15.1% and 15.7%, respectively; hazard ratio, 0.99; 95% confidence interval [CI], 0.71 to 1.39; P = 0.01 for noninferiority; P = 0.95 for superiority). Device-related complications occurred in 31 patients in the subcutaneous ICD group and in 44 in the transvenous ICD group (hazard ratio, 0.69; 95% CI, 0.44 to 1.09); inappropriate shocks occurred in 41 and 29 patients, respectively (hazard ratio, 1.43; 95% CI, 0.89 to 2.30). Death occurred in 83 patients in the subcutaneous ICD group and in 68 in the transvenous ICD group (hazard ratio, 1.23; 95% CI, 0.89 to 1.70); appropriate shocks occurred in 83 and 57 patients, respectively (hazard ratio, 1.52; 95% CI, 1.08 to 2.12). CONCLUSIONS: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to ...
Document Type: article in journal/newspaper
File Description: text
Language: English
Relation: https://discovery.ucl.ac.uk/id/eprint/10108075/1/nejmoa1915932.pdf; https://discovery.ucl.ac.uk/id/eprint/10108075/
Availability: https://discovery.ucl.ac.uk/id/eprint/10108075/1/nejmoa1915932.pdf
https://discovery.ucl.ac.uk/id/eprint/10108075/
Rights: open
Accession Number: edsbas.6F1E2EA9
Database: BASE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://discovery.ucl.ac.uk/id/eprint/10108075/1/nejmoa1915932.pdf#
    Name: EDS - BASE (ns324271)
    Category: fullText
    Text: View record from BASE
Header DbId: edsbas
DbLabel: BASE
An: edsbas.6F1E2EA9
RelevancyScore: 894
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 893.994323730469
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Subcutaneous or Transvenous Defibrillator Therapy
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Knops%2C+RE%22">Knops, RE</searchLink><br /><searchLink fieldCode="AR" term="%22Olde+Nordkamp%2C+LRA%22">Olde Nordkamp, LRA</searchLink><br /><searchLink fieldCode="AR" term="%22Delnoy%2C+P-PHM%22">Delnoy, P-PHM</searchLink><br /><searchLink fieldCode="AR" term="%22Boersma%2C+LVA%22">Boersma, LVA</searchLink><br /><searchLink fieldCode="AR" term="%22Kuschyk%2C+J%22">Kuschyk, J</searchLink><br /><searchLink fieldCode="AR" term="%22El-Chami%2C+MF%22">El-Chami, MF</searchLink><br /><searchLink fieldCode="AR" term="%22Bonnemeier%2C+H%22">Bonnemeier, H</searchLink><br /><searchLink fieldCode="AR" term="%22Behr%2C+ER%22">Behr, ER</searchLink><br /><searchLink fieldCode="AR" term="%22Brouwer%2C+TF%22">Brouwer, TF</searchLink><br /><searchLink fieldCode="AR" term="%22Kääb%2C+S%22">Kääb, S</searchLink><br /><searchLink fieldCode="AR" term="%22Mittal%2C+S%22">Mittal, S</searchLink><br /><searchLink fieldCode="AR" term="%22Quast%2C+A-FBE%22">Quast, A-FBE</searchLink><br /><searchLink fieldCode="AR" term="%22Smeding%2C+L%22">Smeding, L</searchLink><br /><searchLink fieldCode="AR" term="%22van+der+Stuijt%2C+W%22">van der Stuijt, W</searchLink><br /><searchLink fieldCode="AR" term="%22de+Weger%2C+A%22">de Weger, A</searchLink><br /><searchLink fieldCode="AR" term="%22de+Wilde%2C+KC%22">de Wilde, KC</searchLink><br /><searchLink fieldCode="AR" term="%22Bijsterveld%2C+NR%22">Bijsterveld, NR</searchLink><br /><searchLink fieldCode="AR" term="%22Richter%2C+S%22">Richter, S</searchLink><br /><searchLink fieldCode="AR" term="%22Brouwer%2C+MA%22">Brouwer, MA</searchLink><br /><searchLink fieldCode="AR" term="%22de+Groot%2C+JR%22">de Groot, JR</searchLink><br /><searchLink fieldCode="AR" term="%22Kooiman%2C+KM%22">Kooiman, KM</searchLink><br /><searchLink fieldCode="AR" term="%22Lambiase%2C+PD%22">Lambiase, PD</searchLink><br /><searchLink fieldCode="AR" term="%22Neuzil%2C+P%22">Neuzil, P</searchLink><br /><searchLink fieldCode="AR" term="%22Vernooy%2C+K%22">Vernooy, K</searchLink><br /><searchLink fieldCode="AR" term="%22Alings%2C+M%22">Alings, M</searchLink><br /><searchLink fieldCode="AR" term="%22Betts%2C+TR%22">Betts, TR</searchLink><br /><searchLink fieldCode="AR" term="%22Bracke%2C+FALE%22">Bracke, FALE</searchLink><br /><searchLink fieldCode="AR" term="%22Burke%2C+MC%22">Burke, MC</searchLink><br /><searchLink fieldCode="AR" term="%22de+Jong%2C+JSSG%22">de Jong, JSSG</searchLink><br /><searchLink fieldCode="AR" term="%22Wright%2C+DJ%22">Wright, DJ</searchLink><br /><searchLink fieldCode="AR" term="%22Tijssen%2C+JGP%22">Tijssen, JGP</searchLink><br /><searchLink fieldCode="AR" term="%22Wilde%2C+AAM%22">Wilde, AAM</searchLink><br /><searchLink fieldCode="AR" term="%22PRAETORIAN+Investigators%22">PRAETORIAN Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: The New England Journal of Medicine , 383 (6) pp. 526-536. (2020)
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2020
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: University College London: UCL Discovery
– Name: Abstract
  Label: Description
  Group: Ab
  Data: BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies. METHODS: We conducted a noninferiority trial in which patients with an indication for an ICD but no indication for pacing were assigned to receive a subcutaneous ICD or transvenous ICD. The primary end point was the composite of device-related complications and inappropriate shocks; the noninferiority margin for the upper boundary of the 95% confidence interval for the hazard ratio (subcutaneous ICD vs. transvenous ICD) was 1.45. A superiority analysis was prespecified if noninferiority was established. Secondary end points included death and appropriate shocks. RESULTS: A total of 849 patients (426 in the subcutaneous ICD group and 423 in the transvenous ICD group) were included in the analyses. At a median follow-up of 49.1 months, a primary end-point event occurred in 68 patients in the subcutaneous ICD group and in 68 patients in the transvenous ICD group (48-month Kaplan-Meier estimated cumulative incidence, 15.1% and 15.7%, respectively; hazard ratio, 0.99; 95% confidence interval [CI], 0.71 to 1.39; P = 0.01 for noninferiority; P = 0.95 for superiority). Device-related complications occurred in 31 patients in the subcutaneous ICD group and in 44 in the transvenous ICD group (hazard ratio, 0.69; 95% CI, 0.44 to 1.09); inappropriate shocks occurred in 41 and 29 patients, respectively (hazard ratio, 1.43; 95% CI, 0.89 to 2.30). Death occurred in 83 patients in the subcutaneous ICD group and in 68 in the transvenous ICD group (hazard ratio, 1.23; 95% CI, 0.89 to 1.70); appropriate shocks occurred in 83 and 57 patients, respectively (hazard ratio, 1.52; 95% CI, 1.08 to 2.12). CONCLUSIONS: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to ...
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article in journal/newspaper
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: text
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://discovery.ucl.ac.uk/id/eprint/10108075/1/nejmoa1915932.pdf; https://discovery.ucl.ac.uk/id/eprint/10108075/
– Name: URL
  Label: Availability
  Group: URL
  Data: https://discovery.ucl.ac.uk/id/eprint/10108075/1/nejmoa1915932.pdf<br />https://discovery.ucl.ac.uk/id/eprint/10108075/
– Name: Copyright
  Label: Rights
  Group: Cpyrght
  Data: open
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsbas.6F1E2EA9
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.6F1E2EA9
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Text: English
    Titles:
      – TitleFull: Subcutaneous or Transvenous Defibrillator Therapy
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Knops, RE
      – PersonEntity:
          Name:
            NameFull: Olde Nordkamp, LRA
      – PersonEntity:
          Name:
            NameFull: Delnoy, P-PHM
      – PersonEntity:
          Name:
            NameFull: Boersma, LVA
      – PersonEntity:
          Name:
            NameFull: Kuschyk, J
      – PersonEntity:
          Name:
            NameFull: El-Chami, MF
      – PersonEntity:
          Name:
            NameFull: Bonnemeier, H
      – PersonEntity:
          Name:
            NameFull: Behr, ER
      – PersonEntity:
          Name:
            NameFull: Brouwer, TF
      – PersonEntity:
          Name:
            NameFull: Kääb, S
      – PersonEntity:
          Name:
            NameFull: Mittal, S
      – PersonEntity:
          Name:
            NameFull: Quast, A-FBE
      – PersonEntity:
          Name:
            NameFull: Smeding, L
      – PersonEntity:
          Name:
            NameFull: van der Stuijt, W
      – PersonEntity:
          Name:
            NameFull: de Weger, A
      – PersonEntity:
          Name:
            NameFull: de Wilde, KC
      – PersonEntity:
          Name:
            NameFull: Bijsterveld, NR
      – PersonEntity:
          Name:
            NameFull: Richter, S
      – PersonEntity:
          Name:
            NameFull: Brouwer, MA
      – PersonEntity:
          Name:
            NameFull: de Groot, JR
      – PersonEntity:
          Name:
            NameFull: Kooiman, KM
      – PersonEntity:
          Name:
            NameFull: Lambiase, PD
      – PersonEntity:
          Name:
            NameFull: Neuzil, P
      – PersonEntity:
          Name:
            NameFull: Vernooy, K
      – PersonEntity:
          Name:
            NameFull: Alings, M
      – PersonEntity:
          Name:
            NameFull: Betts, TR
      – PersonEntity:
          Name:
            NameFull: Bracke, FALE
      – PersonEntity:
          Name:
            NameFull: Burke, MC
      – PersonEntity:
          Name:
            NameFull: de Jong, JSSG
      – PersonEntity:
          Name:
            NameFull: Wright, DJ
      – PersonEntity:
          Name:
            NameFull: Tijssen, JGP
      – PersonEntity:
          Name:
            NameFull: Wilde, AAM
      – PersonEntity:
          Name:
            NameFull: PRAETORIAN Investigators
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-locals
              Value: edsbas
            – Type: issn-locals
              Value: edsbas.oa
          Titles:
            – TitleFull: The New England Journal of Medicine , 383 (6) pp. 526-536. (2020
              Type: main
ResultId 1